In EwS, treatment with thiostrepton, a proteasomal inhibitor reported to physically interact with FOXM1, hindering its ability to bind to its target promoters46 was demonstrated to effectively inhibit tumor growth in mouse xenografts.47 This evidence concerns the gene FOXM1 and neoplasm.